Announcements

2 May 2024
MDPI Insights: The CEO's Letter #11 - 2023 Annual Report, MDPI Awards, STM

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

2023 Annual Report

This is an exciting time of year at MDPI, as we have just released our annual report 2023, recapping the past year and sharing the progress and changes that took place during it.


Stefan Tochev (CEO, MDPI)

Reflecting on 2023, I can't help but think of the changes that have occurred not only at MDPI but also within our industry as a whole. In light of this, I’m reminded that change is the only constant, and that for a publishing enterprise that has experienced rapid growth, adapting to change becomes not only a necessity but also a catalyst for sustained success.

Looking back on the significant ground we covered in 2023, I am pleased to report that the year was marked by a rise in paper submissions, along with a range of initiatives aimed at improving our internal processes and delivering top services to our scientists.

2023 Top-line MDPI Numbers

An important priority for 2023 was to strengthen our editorial policies. Despite a notable increase in the number of papers submitted from 603,000 to 655,000 (+8.6%), there was a decrease in the number of papers published from 303,000 to 285,000 (-5.9%), consistent with the overall trend in the scholarly publishing market. MDPI’s market share in gold open access articles published reached 17% in 2023 (according to Dimensions data).

2023 Open Access Numbers

For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment to, and vision for, an open future. This momentum continued in 2023, with 39% of the 4.16 million articles and reviews published as gold full-OA, 15% as gold hybrid-OA, 8% as bronze-OA, and 3% as green-OA, relative to 35% behind a paywall. In terms of gold OA (full or hybrid) articles and reviews published, MDPI leads the way in terms of total articles published in 2023.

MDPI is the trusted and preferred OA publisher for the scholarly community

However, in 2023, we saw a downward trend in publication numbers compared to 2022. This trend was also seen in total OA publications. While the number of submissions increased, the decline in MDPI publications can be attributed to several factors, such as improved scrutiny in our peer-review process, including the evaluation of content scope and higher rejection rates, and a post-pandemic decrease in research related to COVID-19 papers.

Download 2023 MDPI Annual Report.
Access 2023 Digital Report.

Impactful Research

Recognizing Scholars – MDPI Awards

MDPI is committed to empowering young researchers as they embark on their careers. In 2023, our journals hosted a total of 400 awards, receiving 8,839 applications and nominations. The evaluation committees selected 959 winners, with the total budget for these awards amounting to CHF 546,500.

For more information about MDPI awards, applications, and winners, please click here

The following awards recognize scholars and the impact of their research, including Young Investigator Awards, Best PhD Thesis Awards, and Travel Awards for junior researchers.

MDPI Awards – The following awards require an application or a nomination.

Young Investigator Award (CHF 1000–2000 for each winner)
This award acknowledges the achievements of young investigators in research areas relevant to the journal’s scope. Candidates must have received their PhD no more than 10 years prior to the award announcement date and must be nominated.

Best PhD Thesis Award (CHF 500–800 for each winner)
This award recognizes young scholars who have completed outstanding PhD theses in research areas relevant to the journal’s scope. It aims to encourage them to continue their excellent work and make further contributions to their field.

Travel Award (CHF 500–800 for each winner)
This award encourages junior scientists to present their latest research at academic conferences relevant to the journal’s scope, thereby increasing their impact.

Distinguished Scholars
Additionally, 220 awards were granted to the most distinguished authors and reviewers in our journals through Best Paper Awards and Outstanding Reviewer Awards. The following awards are selected by the editorial staff of the journal and do not require an application or a nomination. They exemplify the excellent contributions made by our authors, reviewers, and editors.

These awards exemplify the excellent contributions made by our authors, reviewers, and editors

Best Paper Award (CHF 200–500 for each winner)
This award is granted annually to highlight publications of high quality, scientific significance, and extensive influence.

Outstanding Reviewer Award (CHF 500 for partial winners)
This award is given annually to recognize reviewers who generously contribute their time to reviewing papers and demonstrate thoroughness, professionalism, and timeliness in their reviews.

MDPI also offers awards for specific topics in various research fields:

Carbon Neutrality Award (CHF 500–800 for each winner)
Sponsored by MDPI journal Sustainability, this award recognizes applicants who have made exceptional academic or societal contributions to carbon neutrality, either in general or in relation to a specific carbon-neutrality-related issue.

Intelligent Manufacturing Award (CHF 500–800 for each winner)
Administered by MDPI journal Machines, this award is presented to an individual who has made outstanding academic or societal contributions to the field of intelligent manufacturing.

Granted: World Sustainability Awards

Inside MDPI

MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager

As CEO of the world’s leading OA publisher, I am pleased to announce the official opening of our Korean branch office. With this addition, MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher. This expansion represents more than just an increase in our physical footprint; it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible across the globe.

MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher


Claude Seo (MDPI Korea Office Manager, Seoul)

Claude Seo, who has over 15 years of experience in the academic publishing industry, has been appointed as the Office Manager of the Seoul office. The launch of our Seoul office allows us to better support the Korean scientific community and to further promote the publication of OA journals in the region.

Reflecting on his role, Claude shared that he is:

“Delighted to have been entrusted with this position within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating ourselves into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”

Sungkyunkwan University Joins MDPI’s Institutional Open Access Program

Additionally, I am pleased to share that Sungkyunkwan University has joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDP’s online submission system for institutions and provides APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyunghee University, Chung-Ang University, and the Catholic University of Korea, have adopted IOAP in Korea.

Learn more about MDPI’s collaboration in Korea in my previous CEO Letter, in which I recap our visit to Seoul, South Korea.

Coming Together for Science

4th MMCS: Harnessing the Power of New Drug Modalities

Our conference team successfully managed the 4th Molecules Medicinal Chemistry Symposium, held from 24–26 April in Barcelona, Spain. It was chaired by Prof. Dr. Diego Muñoz-Torrero from the Institute of Biomedicine (IBUB), University of Barcelona, Spain, and Prof. Dr. Simona Collina from the University of Pavia, Italy. In total, there were 84 accepted abstracts and 102 conference attendees from 22 different countries.


From left to right: Prof. Dr. Rino Ragno (Scientific Committee), Dr. Maria Emilia Sousa (Scientific Committee), Prof. Dr. Claudio Viegas Jr. (Scientific Committee), Prof. Dr. Simona Collina (Chair), Prof. Dr. Diego Muñoz-Torrero (Chair), Alvina Wu (Managing Editor, MDPI), Prof. Dr. Roman Dembinski (Scientific Committee), Prof. Dr. Mariana Spetea (Scientific Committee).

The event comprised 12 Invited Speakers, 35 Selected Talks, 10 Flash Poster Presentations, and 39 Posters. The overarching topic of the conference was the impact of the emergence of new drug modalities on drug discovery, with thematic sessions covering topics such as photoactivatable drugs, candidates targeting RNA and epigenetic targets, covalent modifiers, and the development of new anti-cancer agents, among other medicinal chemistry projects.

We are pleased to have received feedback from attendees highlighting the professional approach of the conference chairs and participants, the high quality of the talks, and the overall outstanding organization on the part of the MDPI conference team.

Thank you to the conference sponsors, Fluorochem and IBUB, and to our partnering societies, The Spanish Society for Biochemistry and Molecular Biology (SEBBM), and the Spanish Society of Medicinal Chemistry (SEQT).

Upcoming In-Person Event

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location:
Athens, Greece
Conference Chairs: Prof. Dr. Dimitrios Bikiaris, Prof. Dr. Konstantinos Triantafyllidis, Dr. Ioanna Deligkiozi
We look forward to welcoming experts Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.

Find more upcoming MDPI events here.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

A Report from the Future – STM US Annual Conference 2024


Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board.

MDPI has for a long time been a sponsor of the STM Annual Conferences, held yearly in the US and Frankfurt, and is a trusted partner and supporter of the STM organization. While I have attended the Frankfurt conference for the past three years, this was my first time visiting the Washington, DC session, and I am glad I did.

Although it was a brief trip, I greatly appreciated the opportunity to attend in the company of my colleagues Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board. They always help map some of the new industry trends against MDPI’s operational framework and guidelines. It’s a great group for kicking ideas back and forth on what we can apply at MDPI.

In my experience, STM never fails to deliver. It’s always a great conference for reconnecting with fellow publishers, industry friends, and vendors. As usual, STM this year curated a diverse range of speakers and panels, who proferred valuable knowledge and insights from outside our industry, delivering thought-provoking insights into our field. An example of this was the ‘Trust Panel’ session, which included Alan Schiffres (Managing Director, InfoLinx), who shared a number of the learnings about fraud and risk management from his 40 years in financial services, to help address some of the challenges we are currently facing in the area of publishing integrity.

Launch of STM Trends 2028 Panel

I particularly enjoyed the ‘Launch of STM Trends 2028 Panel’, which presented a report focused on the integration of humans and machines in scholarly publishing. The session highlighted themes such as AI, digitization, and the evolving research ecosystem. The report envisions a future where technology blurs the lines between human and machine involvement in research processes, with significant implications for trust, reputation, and equity. While this presents opportunities for connectivity and knowledge dissemination, it also poses challenges such as disinformation, fragmentation, and geopolitical tensions. We must rely on a wise combination of technology and human agency to navigate this complex landscape and will have to carefully examine its potential impacts on communication and scholarly publishing.

MDPI has joined the STM Integrity Hub. Click here to learn more.

While every presenter brought their own knowledge and personal touch, I was particularly pleased to encounter new speakers such as Heather Whitney (Research Assistant Professor, Radiology, University of Chicago) and Igor Grossmann (Professor of Psychology, University of Waterloo, Canada). Having studied Sociology at the University of Guelph, I have a soft spot for fellow social scientists from Canada, and I was very impressed by Igor’s presentation on ‘The Social Scientist: A View from the Future’ and his participation in the panel session ‘The Future Beyond the Article,’ which was one of my favourites from the conference, given the diversity of perspectives from the panel speakers.

Memorial Park in Washington, DC

On a personal note, this was my first-time visiting Washington, DC, and I’m glad we took an afternoon to visit the Memorial Park, with its incredible monuments to figures ranging from Martin Luther King, Jr. to Abraham Lincoln. The magnitude of the monuments is deeply impressive. I particularly appreciated the Thomas Jefferson memorial and the following quote, which I think speaks to the importance of change and adaptation. It’s something we can apply not only in our industry but also in our personal lives.

"I am not an advocate for frequent changes in laws and constitutions, but laws and institutions must go hand in hand with the progress of the human mind. As that becomes more developed, more enlightened, as new discoveries are made, new truths discovered and manners and opinions change, with the change of circumstances, institutions must advance also to keep pace with the times. We might as well require a man to wear still the coat which fitted him when a boy as a civilized society to remain ever under the regimen of their barbarous ancestors."

– Excerpted from a letter to Samuel Kercheval, July 12, 1816.

Stefan Tochev
Chief Executive Officer
MDPI AG

30 April 2024
MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager

MDPI, the leading Open Access (OA) publisher, announced on Monday that it opened its Korean branch office on 29th April 2024. With this addition, MDPI now operates 21 offices in 12 countries worldwide. Claude Seo, with over 20 years of experience in the academic journal publishing industry, including Nature Publishing Group (NPG), has been appointed as the Office Manager of the Seoul office.

With the establishment of a Seoul office, MDPI aims to actively support Korea scientific communities to further promote the publication of OA journals in the region. As of the end of 2023, Korea ranked sixth worldwide in both submissions and publications of MDPI research papers. MDPI is the number one OA publisher in Korea.


Sungkyunkwan University Joins MDPI’s Institutional Open Access Program

In addition, MDPI announced that Sungkyunkwan University joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDPI online submission system for the institutions and APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyung Hee University, Chung-Ang University and Catholic University of Korea, have adopted IOAP in Korea.

OA aims to break down barriers that have traditionally restricted access to science, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Authors, academia, and scientific communities are rapidly moving toward OA. MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020.


MDPI CEO Visits Seoul, Korea

In March, Stefan Tochev, Chief Executive Officer (CEO) of MDPI, visited Korea and met with various stakeholders including government agencies, research and academic institutions, universities. During his visit, Stefan highlighted that MDPI continues to pave the way for a world where science is accessible to all, supporting a global community of inclusive innovation and collaborative solutions.

Stefan expressed excitement about the new venture, stating, "Today marks a significant milestone for MDPI as we celebrate the opening of our new office in Seoul, Korea. This expansion is more than just an increase in our physical footprint, it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible, participatory, and inclusive across the globe."

Claude Seo, reflecting on his new role, commented, "I am delighted to have been offered this position of trust within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”

For further inquiries, please contact our Seoul office directly.


About MDPI

A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.3 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6000 diligent, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully OA titles.

2 April 2024
MDPI Insights: The CEO's Letter #10 - South Korea, IWD, U2A, Japan

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Stefan Tochev (CEO, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), during media meetings at Prain Agency office in Seoul, South Korea.

Visit to Seoul, South Korea

During my recent visit to South Korea, I had the privilege of meeting various stakeholders, including representatives of government, research institutions, and academia, to understand their needs and communicate MDPI’s commitment to accessible science. Accompanied by my colleagues Dr. Giulia Stefenelli and Dr. Jisuk Kang, I engaged with the Korean scientific community, which is increasingly embracing open access (OA).

As the leading OA publisher in South Korea, MDPI is trusted by local authors and in 2023 enjoyed an approximately 30% share of the OA market. South Korea ranks sixth globally for MDPI in terms of research papers submitted and published.

MDPI and South Korea by Numbers

As at 30 March, over 76,000 MDPI articles have been authored by individuals affiliated with Korean institutions. We have over 1,800 active editorial board members (EBMs) from South Korea, with more than 880 EBMs having an H-index between 26 and 50, including 10 serving as Chief Editors.

“South Korea is the sixth-largest contributor to our total publications”

Over the past five years (2019–2023), nearly 120,000 authors affiliated with South Korean institutes have published with MDPI. Specifically in 2023, we received approximately 25,000 submissions from South Korean authors, publishing close to 13,000 articles, resulting in a rejection rate of 47.4%, which is not far below MDPI’s overall rejection rate of 56.4% in 2023.

Institutional Partnerships with South Korea

I am pleased to share that MDPI has more than 825 institutional partnerships worldwide, with 12 in South Korea, including Kyunghee University, Chung-Ang University, and Inha University, among others.


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), and Stefan Tochev (CEO, MDPI) fielding media questions at Prain PR Agency office in Seoul, South Korea.

Over the past three years (2021–2023), we have had some of the most prestigious academic universities ranked among the top 10 Korean institutions publishing with MDPI. Seoul National University had the highest number of publications with MDPI during those three years, publishing nearly 6,000 papers. Universities such as Korea University and Yonsei University also rank among the top 10 Korean institutions publishing with MDPI.

MDPI Hosts Seminar for Academia and Media

As the world’s leading OA publisher, MDPI is actively democratizing science. This is reflected in the seminars we hosted on 21 March to address questions about our editorial processes and ethical standards. The visit garnered media coverage, reflecting our mission to providing high-quality services and fostering open dialogue in the community.

“MDPI is actively democratizing science”

MDPI in the News


Stefan Tochev (CEO, MDPI) leading a seminar on OA and MDPI at Prain PR Agency office in Seoul, South Korea.

Media coverage generated by our visit to Seoul included the following stories:

“Open access is an unstoppable trend…it will lead the development of the knowledge ecosystem.”

“Papers that the public needs, anyone can use quickly… low-quality publishing is a misunderstanding.”

I greatly appreciate the contributions of everyone who took the time to meet with us, share their stories, and hold us accountable for continuing to provide high-quality publishing services while identifying areas for improvement. I am also excited to announce that we have opened an MDPI office in Seoul and will release a press release on MDPI.com, with details, by the end April 2024. The purpose of the office is to establish a local presence to connect with and support the South Korean academic community through institutional partnerships, conferences, author workshops, stakeholder communications, and more.

Impactful Research

Featured Articles on Women’s Leadership and Healthcare

In celebration of International Women’s Day (8 March 2024), MDPI curated a collection of research articles on various topics, including women’s leadership, reproductive health, preventive healthcare, and a selection of articles from our journal Women.

Women’s Leadership

Women’s Reproductive Health

Women’s Preventive Healthcare

Featured Articles in MDPI Journal Women

Below are a few articles from Women, our journal focused on women’s health, the social determinants of health, and the healthcare system that serves women. The aim of Women is to encourage academics to publish their experimental and theoretical results in detail, to aid reproducibility, and in an engaging style, to aid comprehensibility.

Inside MDPI

 

Championing Women’s Healthcare and Access to Healthcare Information

MDPI colleagues from our offices joined in celebrating #IWD2024. In doing so, we emphasized key missions that encompass:

  • Empowering women to assume leadership and decision-making roles in both business and science.
  • Helping women and girls make informed decisions about their health.
  • Recruiting and developing female talent and fostering inclusive workplace environments.

“We are thrilled to recognize the accomplishments of women scientists”

I am proud to see our colleagues enthusiastically supporting the International Women’s Day call to ‘Inspire Inclusion!’ The heart-hands in the collage below symbolize our appreciation of the achievements of women researchers and the recognition of the trailblazers who have courageously made a mark on societies past and present.

We are thrilled to recognize the accomplishments of women scientists through our many MDPI awards and by highlighting success stories. As inspirational figures, female scientists are paving the way for the next generation of women aspiring to pursue careers in engineering, life sciences, computing, and various other STEM fields.

“I consider myself lucky because I work with incredibly talented women who inspire me every day.”
– Dr. Alessandra Pasut, Winner of MDPI's ‘Biology 2023 Young Investigator Award’

“It’s really important to find a supportive and enabling environment in which to do your science; it would have a big impact on you as a person and on your scientific outputs.”
– Dr. Rhea Longley, Winner of the ‘Pathogens 2023 Young Investigator Award’

Open-access publishing, in particular, allows early-career women researchers to share their work more widely, potentially attracting mentorship opportunities and collaborations. This support is crucial for career development and advancement.

Coming Together for Science

MDPI Joins United2Act in Collective Fight to Stop Paper Mills

In my February 2024 CEO Letter, I highlighted some of our recent initiatives aimed at bolstering our commitment to research integrity, including joining the STM Integrity Hub and expanding our Research Integrity and Publication Ethics team (RIPE). Continuing our efforts in coming together for science, I am pleased to share our participation in the United2Act initiative.

The text below is taken from our official announcement:

United2Act represents an international group of stakeholders in the publishing industry committed to addressing the collective challenge posed to research integrity by paper mills.

Scientists and academic publishers have increasingly noted the alarming proliferation of paper mills, recognized as fraudulent entities seeking to manipulate the publication process for financial profit. These entities engage in fraudulent practices such as falsifying or fabricating data, selling co-authorship of fake papers, manipulating peer review, and including inappropriate citations. These actions pose a significant threat to the integrity of the scholarly record, prompting widespread concern among those involved in the academic community.

MDPI has been actively contributing to combat the undermining of the scientific record. Our editors employ a set of tools to detect potential ethical breaches within a manuscript and to tackle the issue of fake papers.

United2Act’s consensus statement is the outcome of a virtual summit held in May 2023. It involved the participation of research bodies, publishers, researchers/sleuths, universities, and publishing infrastructure from 15 countries and resulted in a Consensus Statement outlining five key areas of action for all stakeholders:

  • Education and awareness
  • Improve post-publication corrections
  • Facilitate and organise research on paper mills
  • Enable the development of trust markers
  • Facilitate dialogue between stakeholders

MDPI is committed to promoting transparency and integrity in scholarly publishing and is continuing to work closely with the scientific community toward this goal.

Closing Thoughts


Left to right: Ryo Hirayama (Marketing Specialist, MDPI), Takashi Sasabe (Marketing Specialist, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Stefan Tochev (CEO, MDPI), at MDPI’s office in Tokyo, Japan.

Visit to Tokyo and Kyoto, Japan

In March, I had the opportunity to visit our Tokyo office and engage with stakeholders in Tokyo and Kyoto. During the visit, I also recorded a video message to welcome Japanese scholars working with MDPI and to highlight our operations in Japan.

We held meetings with Editors-in-Chief, librarians, scholars, and external consultants to gather feedback on our efforts to enhance our reputation and explore additional steps we can take in that direction. Japan's rich cultural heritage, characterized by tradition, respect, and formality, provided valuable insights into meeting the publishing needs specific to Japan.

Japan’s Open Access statistics

Over the years, we have seen a shift from subscription-only to gold OA publishing in Japan, despite the lack of an official mandate. Here are some statistics:

  • 2012: 68% of articles were subscription-only, 6% were green Open Access, and 8% were gold Open Access.
  • 2016: 55% of articles were subscription-only, 6% were green Open Access, and 20% were gold Open Access.
  • 2022: 43% of articles were subscription-only, 7% were green Open Access, and 39% were gold Open Access.

To learn more about the history of OA in Japan as well as about future trends, please read this blog post.

“Japan is the ninth-largest contributor to our total publications”


Left to right: Stefan Tochev (CEO, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI) visiting Kyoto University in Kyoto, Japan.

MDPI and Japan by Numbers

As at 1 April, over 50,000 MDPI articles have been authored by scholars affiliated with Japanese institutions, making the country the ninth-largest contributor to our total publications. Over the past three years (2020–2023), nearly 90,000 authors affiliated with Japanese institutes have published with MDPI, and we have collaborated with over 4,600 Guest Editors from Japan.

In 2023, we published over 8,200 papers from authors associated with Japanese institutions. MDPI collaborates with 41 institutional partnerships in Japan, including the University of Tokyo, Hokkaido University, and Nagoya University. We have over 2,100 active EBMs from Japan, more than 1,050 EBMs having an H-index between 26 and 50, including 13 serving as Editors-in-Chief.

General Feedback – a side note

A general takeaway from our discussions with stakeholders from around the world is that negative perceptions of MDPI often stem from misinformation, misconceptions, or misunderstandings about MDPI and our practices. While we acknowledge our mistakes and work diligently to address them, maintaining a strong editorial procedure and robust peer-review process, I find that educating stakeholders about our how we do what we do and our ongoing improvements tends to help shift opinions.

That said, we recognize the importance of addressing individual concerns. We take feedback seriously and are continuously working to get better while not compromising the core principles that millions of authors appreciate about MDPI.

Stefan Tochev
Chief Executive Officer
MDPI AG

28 March 2024
Viruses | “Viruses 2024—A World of Viruses” Conference Held Successfully

Viruses pose a continuous threat to global health, making their study an ongoing imperative in scientific research. 

Following the successful MDPI Viruses conferences held in Basel (2016), Barcelona (2018 and 2020), and online (2022), the 2024 edition recently convened in Barcelona, Spain from 14 to 16 February. Entitled “Viruses 2024 – A World of Viruses”, this conference served as a platform for international expert scientists and researchers to disseminate their latest discoveries in viral pathogenesis and immune response. 

Covering a wide array of topics including molecular and cellular biology, immunology, epidemiology, and public health, this conference facilitated meaningful discussions on the most pertinent issues in current virology.

The Auditorium and Convention Center—AXA

The event was jointly organized by MDPI and the journal Viruses (ISSN: 1999-4915), with support from the American Society for Virology, the Spanish Society of Virology, the Australasian Virology Society, and the World Society for Virology as collaborating societies. 

With 241 attendees from 40 different countries and 190 abstracts received, the congress achieved remarkable participation. Led by Dr. Eric Freed (Editor-in-Chief of Viruses from the National Cancer Institute, NIH—Frederick, MD, USA) and Dr. Albert Bosch (University of Barcelona, Spain), the scientific committee organized sessions covering a diverse range of topics in virology research:

  • General topics in virology;
  • Antiviral therapies, vaccines, and host defenses;
  • Antiviral innate immunity;
  • The structure and mechanisms of viral replication;
  • Virus–host interactions;
  • Pathogenesis and viral evolution. 

Participants during the conference 

In this post, we will provide you with the highlights of the three days of the “Viruses 2024 – A World of Viruses” conference. 

Opening Presentations
The conference began with one of the most anticipated talks by all participants and the one that brought together the largest number of attendees in the auditorium: the presentation of Dr. Charles M. Rice (Rockefeller University, New York, USA) as a guest speaker.  

Dr. Charles M. Rice during his presentation 

Dr. Rice is a leading figure in Flaviviridae research, particularly in hepatitis C virus (HCV) studies. His extensive career has contributed significantly to our understanding of HCV protein biogenesis and structure. His research group developed the first infectious molecular clone of HCV, along with essential cell culture systems and animal models for studying virus replication and antiviral treatments. 

With over 500 published articles, Dr. Rice's pivotal role in HCV discovery and hepatitis treatment earned him the 2020 Nobel Prize in Physiology or Medicine (shared with Harvey James Alter and Michael Houghton). 

In his opening presentation, Dr. Rice provided a captivating overview of HCV identification history and the quest for a global cure. He also discussed recent advancements in hepatitis B virus (HBV) research, addressing its significant impact on global health. 

Dr. Luis Enjuanes during his presentation 

The second keynote was delivered by Dr. Luis Enjuanes (National Center for Biotechnology, CNB-CSIC, Madrid, Spain), a highly experienced researcher with over 35 years of expertise in coronavirus studies. His current focus lies in investigating the replication mechanisms, transcription, virulence, and virus–host interactions of coronaviruses. 

In his engaging presentation, Dr. Enjuanes provided insights into the origin and spread of the virus responsible for the recent COVID-19 pandemic. He highlighted the latest scientific evidence, indicating a zoonotic origin of the SARS-CoV-2 virus. 

Impressions of Attendees


Dr. Eric Freed

Dr. Eric Freed, Editor-in-Chief of the Viruses journal, delivered an enlightening presentation on the ongoing challenges in controlling the HIV/AIDS pandemic. Reflecting on the congress, he expressed his satisfaction with the diverse array of oral presentations:

“We have had a fantastic group of speakers, Nobel Prize laureate (Dr. Rice) and Dr. Enjuanes, along with an excellent variety of guest speakers and some outstanding Ph.D. and postdoc students who have presented excellent work, oral presentations, and posters on their research.” 

Professor Mikael Skurnik, associate editor of the journal Viruses, presented his work on the enigmatic Jumbo YerA41 bacteriophage from Yersinia YerA41 to open the session on the structure and mechanisms of viral replication. During his interview, he humorously remarked, “Since most of my colleagues work with plant or animal viruses, and I work with bacterial viruses and bacteriophages, I sometimes feel a little lonely here.” He further added, “This conference provides an excellent opportunity to witness the progress in virology research, which is truly inspiring.”  

Professor Mikael Skurnik during his presentation 

Nefer Candance Dossou 

Nefer Candance Dossou was the last speaker of the conference, closing the session on viral pathogenesis and evolution. “The best thing for me is the quality of the guest speakers. The presentation by Dr. Charles M. Rice, who received the Nobel Prize in 2020, has been one of the best moments of this congress.” 

Poster Sessions
The two poster sessions took place on the second and third days of the conference. During the lunch break and afternoon, many attendees took the chance to familiarize themselves with the poster presentations. It was a perfect occasion for Ph.D. students and young researchers to engage in discussions regarding their projects in the fascinating world of virology in an inspiring environment. 

Poster session 

Awards Ceremony
Another highlight of the conference was the Viruses awards ceremony. Dr. Carolien van de Sandt was presented with the commemorative plaque of the Viruses 2022 Early Career Investigator award, along with CHF 1000, by the Editor-in-Chief of Viruses, in recognition of her exceptional achievements as a young researcher. Dr van de Sandt is interested in the mechanisms underlying the gain and loss of virus-specific CD8+ T-cell function across the human lifespan and in high-risk groups. Her research is of great importance for the development of broadly protective vaccine strategies that aim to harness CD8+ T-cells. 

Dr. Carolien van de Sandt receiving the plaque commemorating the Viruses 2022 Early Career Investigator award 

Additionally, the winners for Best Poster and Best Oral Presentation were announced to recognize the most outstanding works presented during the three days of the conference. Matty Allan received the Best Poster award for his work entitled “Long-Range RNA:RNA Base Pairing Regulates Active Conformations of Frameshift Stimulating Elements in Coronaviruses” (awarded EUR 300). Rebekah Gullberg was awarded the Best Oral Presentation for her talk on “SARS-CoV-2 Virus-Like Particles Reveal Chaperones of Viral Assembly” (endowed with EUR 500). These awards not only celebrate the achievements of the winners but also serve as inspiration and motivation for the rest of the attendees toward scientific excellence. 

Matty Allan receiving the award for Best Poster  

Rebekah Gullberg receiving the Best Oral Presentation certificate 

Special Issue: “Viruses 2024—A World of Viruses”

We would like to highlight that the participants of this conference can submit their work to the collection “Viruses 2024 – A World of Viruses” edited by Dr. Freed in the Viruses journal. 

Symposium participants, as well as all researchers working in the field, are cordially invited to contribute original research papers or reviews to this Special Issue of Viruses. You can find more information here

The Viruses journal is indexed in the main databases: Scopus, SCIE (Web of Science), and PubMed, among others. Its current Impact Factor is 4.7 (2022) and it has a Citescore of 7.1 (2022). 

The MDPI conference team that participated in the event 

You can also explore the vibrant atmosphere of the conference through our video recap by clicking here

The Viruses conference has established itself as a leading event in the field of virology for researchers worldwide. We look forward to the next edition of Viruses 2026!

27 March 2024
Viruses | Highly Cited Reviews in 2022

1. “Current Trend in Antiviral Therapy for Chronic Hepatitis B”
by Rong-Nan Chien and Yun-Fan Liaw
Viruses 2022, 14(2), 434; https://doi.org/10.3390/v14020434
Available online: https://www.mdpi.com/1999-4915/14/2/434


2. “Viral Shrimp Diseases Listed by the OIE: A Review”
by Dain Lee, Young-Bin Yu, Jae-Ho Choi, A-Hyun Jo, Su-Min Hong, Ju-Chan Kang and Jun-Hwan Kim
Viruses 2022, 14(3), 585; https://doi.org/10.3390/v14030585
Available online: https://www.mdpi.com/1999-4915/14/3/585

3. “COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies”
by Domenico Iacopetta, Jessica Ceramella, Alessia Catalano, Carmela Saturnino, Michele Pellegrino, Annaluisa Mariconda, Pasquale Longo, Maria Stefania Sinicropi and Stefano Aquaro
Viruses 2022, 14(3), 573; https://doi.org/10.3390/v14030573
Available online: https://www.mdpi.com/1999-4915/14/3/573

4. “Antiviral Drug Discovery for the Treatment of COVID-19 Infections”
by Teresa I. Ng, Ivan Correia, Jane Seagal, David A. DeGoey, Michael R. Schrimpf, David J. Hardee, Elizabeth L. Noey and Warren M. Kati
Viruses 2022, 14(5), 961; https://doi.org/10.3390/v14050961
Available online: https://www.mdpi.com/1999-4915/14/5/961

5. “Monkeypox, a Literature Review: What Is New and Where Does This concerning Virus Come From?”
by Giorgio Tiecco, Melania Degli Antoni, Samuele Storti, Lina Rachele Tomasoni, Francesco Castelli and Eugenia Quiros-Roldan
Viruses 2022, 14(9), 1894; https://doi.org/10.3390/v14091894
Available online: https://www.mdpi.com/1999-4915/14/9/1894

6. “SARS-CoV-2: Evolution and Emergence of New Viral Variants”
by Verónica Roxana Flores-Vega, Jessica Viridiana Monroy-Molina, Luis Enrique Jiménez-Hernández, Alfredo G. Torres, José Ignacio Santos-Preciado and Roberto Rosales-Reyes
Viruses 2022, 14(4), 653; https://doi.org/10.3390/v14040653
Available online: https://www.mdpi.com/1999-4915/14/4/653

7. “Hepatitis B Virus-Associated Hepatocellular Carcinoma”
by Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo and Antonio Craxì
Viruses 2022, 14(5), 986; https://doi.org/10.3390/v14050986
Available online: https://www.mdpi.com/1999-4915/14/5/986

8. “ACE2-Independent Alternative Receptors for SARS-CoV-2”
by Suhyeon Lim, Monica Zhang and Theresa L. Chang
Viruses 2022, 14(11), 2535; https://doi.org/10.3390/v14112535
Available online: https://www.mdpi.com/1999-4915/14/11/2535

9. “An Updated Review on SARS-CoV-2 Infection in Animals”
by Shujuan Cui, Yimeng Liu, Jiachen Zhao, Xiaomin Peng, Guilan Lu, Weixian Shi, Yang Pan, Daitao Zhang, Peng Yang and Quanyi Wang
Viruses 2022, 14(7), 1527; https://doi.org/10.3390/v14071527
Available online: https://www.mdpi.com/1999-4915/14/7/1527

10. “In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success”
by Tea Glonti and Jean-Paul Pirnay
Viruses 2022, 14(7), 1490; https://doi.org/10.3390/v14071490
Available online: https://www.mdpi.com/1999-4915/14/7/1490

4 March 2024
MDPI Insights: The CEO's Letter #9 - Romania, Research Integrity, Viruses

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Reka Kovacs (Deputy Office Manager, MDPI), Stefan Tochev (CEO, MDPI), and Sandra Ana Spatariu (Office Manager, MDPI) at the MDPI office in Cluj, Romania.

MDPI’s Impact on Romania

In February, I visited our office in Cluj, Romania. I worked closely with our senior office managers and various teams, including the departments of training, marketing and conferences, as well as our journal relationship specialists, reviewing our service to the local scholarly community. During the visit, I also met with representatives from Babes-Bolyai University and the Technical University of Cluj-Napoca. Our multifunctional Romanian office plays an important role in supporting our collaborations with the local market as well as helping to meet MDPI’s overall business needs.


Feedback and strategy meeting with a group of MDPI’s Journal Relationship Specialists at the MDPI office in Cluj, Romania.

With 22,436 articles, Romania ranks as a top 20 contributing country to MDPI’s total number of papers published as at 28 February 2024. This highlights the importance of our collaboration with Romanian-affiliated authors and the growing opportunity to support their publishing needs. MDPI is one of the few academic publishers with a significant presence in Romania, boasting over 360 colleagues across our offices in Bucharest and Cluj. We are also proud to hire colleagues from local institutions to launch their careers within publishing.

Romania ranks as a top 20 contributing country.

The Numbers: 2019–2023

MDPI has seen a healthy increase in submissions from Romanian authors over the past three years, from 8,439 in 2021 to 11,866 by end of 2023, with most submissions going to journals such as Sustainability, Medicina, Diagnostics, IJMS, Applied Sciences, and JCM. From 2019 to 2023, MDPI published articles from 32,145 authors affiliated with Romanian institutions. Over those years, we have worked with Romanian Guest Editors on nearly 3,000 occasions to support their Special Issue and Topical collections.

With more than 300 Editorial Board Members from Romania, 34 appear on the board of Mathematics, 27 on Materials, 19 on Polymers, 18 on Coatings, and 16 on Molecules, while three serve as Section Editors-in-Chief (SEiC) on our journals Coatings (3.4 IF, 4.6 Citescore), Magnetochemistry (2.7 IF, 3.5 Citescore), and Chemosensors (4.2 IF, 3.9 Citescore).

Institutional Open Access Programs

Our commitment to working with institutions is evident in Romania, where we have established eight Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Bucharest, the University of Medicine and Pharmacy Cluj-Napoca, and most recently the National Institute for Laser, Plasma and Radiation Physics.

Our growth and presence in Romania are a true testament.

We also have IOAP agreements with Babes-Bolyai University and the Technical University of Cluj-Napoca, where I had the opportunity to meet senior stakeholders during my visit. Below are a few photos capturing our meeting with Prof. Radu Silaghi-Dumitrescu (Head of Faculty of Chemistry, Babes-Bolyai University) at the MDPI office in Cluj, Romania, along with a photo from our meeting with Vice Deans Nicoleta Cobarzan, Nicoleta Ilies, and Hoda Gavril, from the faculty of Civil Engineering at the Technical University of Cluj, Romania.


Our growth and presence in Romania are a true testament to the service we provide to the scholarly community and the relationships we foster in that region. We look forward to continuing to support Romanian scholars and institutions by providing a valuable and trusted experience with MDPI, the leader in open access publishing.

Impactful Research

MDPI Joins the STM Integrity Hub

MDPI has long been a supporter and partner of STM, with our involvement ranging from sponsoring and attending events to helping organize event programs. By joining the STM Integrity Hub, we aim to further our commitment to STM initiatives aimed at safeguarding the integrity of science.

“We are pleased to welcome MDPI as the 35th organisation participating in the Hub. This expansion is critical, as every new member enhances our capacity to prevent fraudulent submissions from entering the academic record.”

Joris van Rossum, Director of Research Integrity, STM

MDPI operates in full alignment with STM Integrity Hub's values of shared data and experiences. We strongly believe in collaboration and open exchange for the purposes of creating a holistic approach to support research integrity at MDPI itself and across the entire academic publishing industry. The Integrity Hub is an excellent example of how publishers can come together to jointly address industry-wide challenges related to research integrity, such as manuscripts that breach research integrity standards and paper-mills.

I look forward to our Research Integrity and Publication Ethics Team (RIPE) team immersing themselves in this initiative, exchanging information, best practices, and tools for the benefit of the entire scholarly ecosystem. We believe that ethical publishing standards should be implemented across the board, and we aim to be rigorous in our approach, addressing research integrity issues and improving the impact of published research.

Inside MDPI

MDPI Expands Research Integrity and Publication Ethics Team (RIPE)

In addition to external collaborations and joint initiatives aimed at further strengthening our commitment to research integrity, we are also enhancing our internal efforts. This includes improving our processes and guidelines and expanding our teams and departments to ensure quality assurance throughout our publishing process.

We are pleased to announce the expansion of our Research Integrity and Publication Ethics Team (RIPE) at MDPI. The RIPE team has recently welcomed new colleagues, each bringing unique skills and a personal commitment to prioritize ethical considerations in all our work.

The demand for research integrity and high ethical standards in academic publishing is steadily rising across our industry. Our expanded RIPE team will work to enhance and align our practices with industry best practices, ensuring excellence in research integrity and publication ethics.


Stefan Tochev (CEO, MDPI) introduces Dr. Tim Tait-Jamieson (Research Integrity Lead, MDPI) for his presentation on MDPI’s Retraction and Approval Process to a group of Journal Relationship Specialists at the MDPI office in Cluj, Romania: “The demand for research integrity and publication ethics is steadily rising across our industry.”

Introducing our Research Integrity and Publication Ethics Team

Led by Dr. Tim Tait-Jamieson (Research Integrity Lead), the RIPE team comprises Dr. Ivana Resanovic (Research Integrity Manager), Dr. Lavinia Rogojina (Research Integrity Manager), Ms. Diana Apodaritei (Research Integrity Specialist), Dr. Zoltan Mihaly (Research Integrity Specialist), Mr. Aleksandar Đukić (Research Integrity Specialist), Ms. Ana Stankovic (Research Integrity Specialist), and Ms. Anna Pena (Publication Ethics Assistant).

Please click here to access everything that you need to know about MDPI’s Research and Publication Ethics.

With this span of complementary roles, the RIPE team collaborates directly with journal editorial teams and works closely with various departments, including our Scientific Office Board and our Journal Relationship Specialists. The team’s primary objectives are to help prevent issues regarding research integrity and publication ethics during peer review, uphold MDPI’s ethics policies, adhere to industry standards, and resolve publication ethics and research integrity issues and complaints.

Quality Updates to Special Issues Oversight

At MDPI, we are committed to reviewing policies pertaining to the quality of research. In this blog post, Shaheena Patel (Communications Associate, MDPI), outlines two recent updates to MDPI journal processes. These updates pertain to Special Issue (SI) quality guidelines, in line with criteria provided by COPE and DOAJ. Alongside the SI updates, details regarding the new minor corrections policy introduced in 2024 are provided in the blog.

The two updates we implemented include greater oversight and the verification of Guest Editor credentials. These guidelines require that Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) take responsibility for overseeing SIs.

PS. Thank you, James Butcher, for featuring this up in your 67th issue of the Journalogy newsletter.

Read more:

Coming Together for Science

Viruses 2024 – A World of Viruses

I am pleased to share the success of our MDPI conference Viruses 2024 – A World of Viruses, held 14-16 February, in Barcelona. With 240 registrations, this event brought together top scientists, researchers, and industry experts from 40 countries to share their findings on the latest developments in viral pathogenesis and immune responses.

Attendees gathered for the 5th edition of the Viruses’ conference, where we hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes, along with 14 invited speakers, 47 selected speakers, and nine flash poster presenters, to discuss the most significant issues in virology today.

Recap on the #Viruses2024 Conference

Take a look at the key moments from MDPI’s Viruses event and please join us in commemorating a gathering for global knowledge and cooperation. A heartfelt thank-you to all attendees; their passion and engagement played a crucial role in making this event an engaging success!

Below are calls to action from the keynote speakers encouraging collaboration and communication:

“There’s never been a better time than now to really take the power that we have both in terms of basic research and also in biotech and pharma to develop antiviral agents.” - Dr. Charles M. Rice, The Rockefeller University, New York, USA

“The collaboration between labs is absolutely essential. Improving initial detection and improving communication is a must for all of us working in science.” - Prof. Dr. Luis Enjuanes, National Center of Biotechnology (CNB-CSIC), Madrid, Spain

Our thanks go to our sponsors and partnering societies, our Viruses journal and editorial team, our Barcelona colleagues, and the social media, conference and other MDPI teams for making this event a memorable occasion. View the event gallery here.

Upcoming In-Person Event

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities
Location: Barcelona, Spain

Esteemed speakers at MMCS 2024 include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.

Find more upcoming MDPI events here.


Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Researcher to Reader (R2R) Conference

From 20–21 February 2024, I had the pleasure of attending the Researcher to Reader (R2R) conference in London, which MDPI has proudly sponsored over the years. The conference programme offered a variety of session formats, including workshops, panel discussions, debates, interviews, presentations, and lightning talks, with opportunities to discuss relevant topics.

We take pride in supporting the scientific community, bringing researchers across the world together to network, exchange ideas and share the latest in science and publishing. In 2023, MDPI invested close to 2 million CHF in sponsoring over 2,000 scientific and publishing-related conferences worldwide.

R2R Peer Review Innovations Workshop

I found the R2R conference to be engaging, with the workshops being particularly enjoyable. My colleague Giulia Stefenelli (Chair of Scientific Office Board) and I participated in the “Peer Review Innovations” workshop, which spanned four sessions over the two days. These sessions explored the future of peer review and how we can improve the peer review process for everyone involved. Notably, the large majority of attendees expressed their opinion that peer review, as currently practiced, requires significant improvement. Together, we collaborated on potential immediate and long-term improvements and innovative processes, aiming to create an ecosystem beneficial to all stakeholders by strengthening submission systems with the aim of reducing threats and making authors more responsible for their work. We also discussed the opportunity for academic institutions to better scrutinize the quality of the work produced and submitted to journals.

Our group comprised publishers, software providers, librarians, and more, bringing diverse perspectives to the discussions. These interactions were relevant to MDPI’s ongoing conversations, providing insights to our efforts. The session also made me appreciate that MDPI is doing well, as the group discussions included the subject of various quality checks that we have already embedded in our processes, ensuring that we keep abreast of industry standards.

The need for an optimized system to incentivize the activities of editors and reviewers was also a focus of discussion, as well as the support that reviewers need from publishers via the provision of strong reports through fixed forms, questionnaires and training.

At MDPI, we are currently auditing our reviewer program to improve reviewer recognition, guidelines, and methods for identifying suitable reviewers, while maintaining our commitment to quality and timeliness.

Congratulations to Mark Carden, Conference Director, and the R2R team for organizing a productive and successful event. PS: The break times were greatly appreciated as well!

Stefan Tochev
Chief Executive Officer
MDPI AG

28 February 2024
Prof. Dr. Alexander Gorbalenya Appointed Associate Editor of Section “General Virology” in Viruses


We are pleased to announce that Prof. Dr. Alexander Gorbalenya has been appointed Associate Editor of the “General Virology” Section of Viruses (ISSN: 1999-4915).

Name: Prof. Dr. Alexander Gorbalenya
Homepage: https://www.universiteitleiden.nl/en/staffmembers/alexander-gorbalenya#tab-1
Affiliation: Department of Leiden University Center of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands
Interests: comparative virus genomics; virus discovery; virus evolution; virus taxonomy; proteolytic processing in viruses; structure and function of nidovirus enzymes

Prof. Dr. Alexander Gorbalenya is Professor Emeritus of medical microbiology, particularly virus bioinformatics, and the former Head of the Virus Evolution and Bioinformatics lab in the Research Section. He held the Leiden University Fund Chair in Applied Bioinformatics in Virology (2009–2017) and was Vice President of the International Committee on Virus Taxonomy (2011–2017).

We are honored that we have the opportunity to introduce Prof. Dr. Alexander Gorbalenya to our editorial team, and we are confident that, with the guidance of our new Associate Editor, we will continue to improve the reputation and quality of Viruses.

For more information about the “General Virology” Section, please visit the following link:
https://www.mdpi.com/journal/viruses/sectioneditors/General_Virology.

31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI and Digital Science Meeting

At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.

As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.


Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.

During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.

What is Altmetric?

You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.

Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.

“Almetric provides visual insights into where research is being discussed”

Sources Tracked by Altmetric


Altmetric badge showing the Altmetric score and colour-coded mention sources.

Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.

The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.

Read more:

Impactful Research

Ten High-Altmetric Articles Published by MDPI

As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.

So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.

Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.

“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort”

J. Pers. Med. 2017, 7(2), 3; https://doi.org/10.3390/jpm7020003

Altmetric page: https://mdpi.altmetric.com/details/20477344

Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News.

“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis”

J. Clin. Med. 2019, 8(3), 404; https://doi.org/10.3390/jcm8030404

Altmetric page: https://mdpi.altmetric.com/details/57654628

Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times.

“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia”

Quaternary 2021, 4(3), 24; https://doi.org/10.3390/quat4030024

Altmetric page: https://mdpi.altmetric.com/details/111086701

Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic.

“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability”

Animals 2020, 10(6), 1007; https://doi.org/10.3390/ani10061007

Altmetric page: https://mdpi.altmetric.com/details/83796184

Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian.

“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study”

Animals 2022, 12(15), 1933; https://doi.org/10.3390/ani12151933

Altmetric page: https://mdpi.altmetric.com/details/133463915

Altmetric shows that this article appeared in 192 news stories from 186 outlets.

How do I use altmetrics?

Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.

Sharing Research Online

For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.

“An Update on Eukaryotic Viruses Revived from Ancient Permafrost”

Viruses 2023, 15(2), 564; https://doi.org/10.3390/v15020564

Altmetric page: https://mdpi.altmetric.com/details/142929875

Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN.

“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications”

Healthcare 2019, 7(1), 1; https://doi.org/10.3390/healthcare7010001

Altmetric page: https://mdpi.altmetric.com/details/53406248

Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes.

“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health”

Int. J. Environ. Res. Public Health 2020, 17(4), 1212; https://doi.org/10.3390/ijerph17041212

Altmetric page: https://mdpi.altmetric.com/details/86529137

Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum.

“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health”

Int. J. Environ. Res. Public Health 2018, 15(3), 431; https://doi.org/10.3390/ijerph15030431

Altmetric page: https://mdpi.altmetric.com/details/34714141

Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review.

“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens”

Animals 2023, 13(4), 590; https://doi.org/10.3390/ani13040590

Altmetric page: https://mdpi.altmetric.com/details/142934305

Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC.

Inside MDPI

MDPI Annual Meeting Celebrations in China

On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.

The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.

“It is essential that we stay connected and share best practices”

I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.

Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.

Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.

The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.

I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!

Coming Together for Science

MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership

We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.

“This initiative reflects our dedication to transparent and inclusive publishing”

TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.

For further details on our Institutional Open Access Program (IOAP), please contact us.

Benefits to MDPI’s IOAP

At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.

For further information, see our IOAP FAQ.

Closing Thoughts

Reflections on the 2024 APE Conference

MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.

The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.

“It's fascinating to see how other publishers are leveraging AI”

Highlights

Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.

In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.

“We can share best practices and lessons learned”

Incorporating MDPI’s Insights into Conferences

I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.

Stefan Tochev
Chief Executive Officer
MDPI AG

30 January 2024
Acknowledgment of the Reviewers of Viruses in 2023

In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Viruses. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.

In 2023, Viruses received 7922 review reports, from 4904 reviewers. This past year, we worked with reviewers from 99 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Viruses family throughout 2023, and we look forward to their continued support in 2024.

The following are the reviewers who have consented to show their names:

A. Abdul Kader Jailani Kalhari Goonewardene
Abdulqadir Nashwan Kaliannan Durairaj
AbdulRahman Saied Kalichamy Alagarasu
Abhinay Gontu Kamaleldin B. Said
Abhishek Anant Kulkarni Karel Kostev
Abiola Adepoju Karel Petrzik
Abraham Pouliakis Karen Bohmwald
Ad De Groof Karen Kopciuk
Adalbert Schiller Karen Kyuregyan
Adam Brufsky Karim Benabdellah
Adam Oberstein Karl Boehme
Adam Whisnant Karoly Toth
Adarsh K. Gupta Katarina Resman Rus
Adetoun Asala Katarzyna Otulak
Adhikarimayum Lakhikumar Sharma Katherine Brown
Aditya Sharma Katie Ardipradja
Adrian Lita Katsunori Okazaki
Adriana Patricia Corredor-Figueroa Kazumoto Murata
Adriano Murrone Kazuo Itabashi
Adrien Breiman Keisuke Ishizawa
Afonso Almeida Ken Rosenthal
Agnieszka Bojarska-Junak Kennio Ferreira-Paim
Agostino Ognibene Kevin Bohannon
Ahmed Ali Kevin Danastas
Ahmed Elbestawy Khaled Alkharsah
Ahmed Mekkawy Ki Hyun Nam
Aiken Dao Kielan McAlinden
Ajay Akhade Kifayatullah Kakar
Akira Aoki Kim Van Vliet
Akira Nakanishi Kin Kui Lai
Akshaya Bhagavathula Klaus Hedman
Alain Le Faou Kok Hian Tan
Alda Natale Koki Taniguchi
Aldemir Branco Oliveira-Filho Konstantinos Protopapas
Alejandra García-Gasca Kouacou Konan
Alejandro Vallejo Krista Delviks-Frankenberry
Aleksander Mendyk Kristen Ogden
Alessandra Lamarca Kun Wen
Alessandra Oliva Kun Zhang
Alessandra Pierangeli Lalit Batra
Alessandro Strumia Lanjing Wei
Alessandro Tavelli Larry Croft
Alexander Alekseev László Hazai
Alexander Bolshoy Laura L. Gibson
Alexander Filatov Laura Medina-Puche
Alexander Ivanov Laura V. Sánchez-Orozco
Alexander Pasternak Laurent Bigarré
Alexander Sprygin Laurie Silva
Alexander Timoshenko Lauro Velazquez-Salinas
Alexander Zakhartchouk Lei Zhang
Alexandra Targovnik Leny Jose
Alfredo J. Lucendo Leonardo Velasco
Ali Abdallah Leszek Tylicki
Alice Monzani Lia Van Der Hoek
Aline Maria Da Silva Líbia Zé-Zé
Alison Talis Lima Lídia Gonçalves
Alkiviadis Vatopoulos Lidija Savić
Altijana Hromic-Jahjefendic Lidija Truncaite
Alvydas Malakauskas Lifeng Zhai
Amanda Seekings Lijuan Yuan
Amelina Albornoz Lin Xu
Amir Ghorbani Linbo Zhao
Amit Goel Linda J. Saif
Amit Kumar Lionel Frangeul
Amrita Saha Vadher Liv Bode
Amy MacNeill Logan Banadyga
Ana Belen Blazquez Martin Lorenzo Casalino
Ana Belen Ruiz-Garcia Lori Rice
Ana Carolina Ewbank Louie Mar Gangcuangco
Ana Cecília Ribeiro Cruz Luana Soares
Ana Cláudia Coelho Lubomira Nikolaeva-Glomb
Ana Espino Luc Swevers
Ana Vasić Luca Bertzbach
Anamika Pandey Luca Scapoli
Anand Kumar Pandey Luca Toti
Ananda Ayyappan Jaguva Vasudevan Lucia Stanciakova
Ananda Tiwari Luciana Costa
Anandi Rajan Luciane Amorim Santos
Anastasia Kotanidou Luigi Pistelli
Anatoly Zherdev Luis Adrián De Jesús González
Andi Krumbholz Luisa De Sordi
Andrea Cara Luisa Rubino
Andrea Fabbri Łukasz Grabowski
Andrea Guarino Łukasz Szeleszczuk
Andrea K. Thoma-Kress Maarit Suomalainen
Andrea Lipińska Maciej Zieliński
Andrea Tinelli Magdalena Dunowska
Andrea V. Peralta Magdalena Mizerska-Kowalska
Andreas Brodehl Magdalena Mroczek
Andreas Jekle Mahamud-Ur Rashid
Andreas Kuhn Mahdi Mahdipour
Andrej Cokan Mahmoud Ibrahim
Andreu Comas-Garcia Mahmoud Khalifa
Andrew Broadbent Mahmoud Singer
Andrew Freedman Maite Freitas Silva Vaslin
Andrew Omame Maksim Filipenko
Andrew Rice Małgorzata Kęsik-Brodacka
Andrew Vaillant Malgorzata Lobocka
Andrey Letarov Mandy Muller
Andrey Sgibnev Manfred Marschall
Angela Pearson Manfred Weidmann
Angus Oli Manish Dhawan
Aniello Maiese Manish Kumar
Anna Costagliola Manoj K. Sekhwal
Anna Dolgova Manoj Kumar
Anna Heitmann Manu Anantpadma
Anna Luganini Manuel Gomez Del Moral
Anna Matczuk Manuela Donalisio
Anna Rosa Garbuglia Marc Fuchs
Anna Shtro Marc Vasse
Anna Speranskaya Marcela Lizano
Anna Szakiel Marcelo Brigido
Anna Taglienti Marco Ciotti
Anna Timofeeva Marco Goeijenbier
Anna Vittoria Carluccio Marco Grodzki
Annalisa Chianese Marco Thomas
Annamaria Pratelli Marcos Romário Matos De Souza
Anne Hosmalin Maria Agallou
Annette Audigé Maria Angelica Guimarães
Antoinette C. Van Der Kuyl María Belén Álvarez Ortega
Antonella Olivero María Carmen Puertas
Antonieta Guerrero-Plata Maria Eugenia Gonzalez
Antonino Catara Maria Isaguliants
Antonio Bertoletti Maria King
Antonio Caputi Maria Lavilla
Antonio Mastino Maria Loureiro
Antonio Tiberini Maria Pia Ferraz
Antonio Toniolo Maria Plummer
Anu Paul Maria Tempesta
Anupam Mukherjee Maria Teresa Bruno
Apostolos Zaravinos Maria Vega Pittao
Aravinthkumar Jayabalan Maria Vittoria Mauro
Arianna Calistri Mariacristina Poliseno
Arianna De Mori Marianna Domán
Arianna M. Hurtado-Monzón Mariano Belaich
Armando Arias Mariarosaria Campise
Arrigo Cicero Marie Pizzorno
Artem Metlin Marija Pljesa-Ercegovac
Arthur Gruber Marilena Gregorini
Artur Słomka Marina Bobkova
Arturo Medrano-Soto Marina Ibragimova
Arun Srivastava Marina Strakhovskaya
Ashley Brown Marine Wasniewski
Atanu Khatua Marino Paroli
Athanasios A. Panagiotopoulos Marion Vermeulen
Athanasios Papakyriakou Marius Masiulis
Athina Geronikaki Mariza Morgado
Atsushi Kato Mark Calcott
Aurobind Vidyarthi Mark Krystal
Avinash Premraj Marko Noerenberg
Ayisa Rodrigues De Oliveira Markus Keller
Azat Gabdulkhakov Marshall Williams
Badr Alshomrani Marta Canuti
Bahaa Jawad Marta Szachniuk
Baicus Anda Marta Vascellari
Baik Lin Seong Martha Brown
Bambang Sugiharto Martijn D. B. Van De Garde
Banhi Biswas Martin Richter
Barbara Klupp Martin Svoboda
Barbara Ruaro Martina Smolic
Barbara Schnierle Martina Torricelli
Barbara Weck Marzia Pucci
Barry Alto Masaaki Miyazawa
Bart Tarbet Masahiro Niikura
Bas B. Oude Munnink Masahiro Yasuda
Basudev Paudyal Masakazu Tanaka
Beatrice Macchi Masayuki Ishikawa
Bela Balint Masfique Mehedi
Benhur Lee Mateusz Babicki
Benjamin Cull Mathieu Dubé
Benjamin Lamp Matias Castells
Benjamin Nilsson-Payant Matt Asare
Benoit Barbeau Matteo Riccò
Bernadett Papp Mauricio Comas-Garcia
Bernardo Bañuelos-Hernández Mauro Giacomelli
Bert Ely Mauro Viganò
Beth Thielen Mayo Yasugi
Betsy C. Herold Md. Abdus Sobur
Biao He Md. Nazmul Islam
Bidisha Mitra Md. Tanvir Rahman
Bihua Nie Meiling Yu
Bin Li Melinda Brindley
Binfeng Yin Melissa Barker-Haliski
Biswas Avik Mengmeng Zhao
Bo Wang Meredith Frazier
Bo Zhou Meret Ricklin
Bobo Mok Michael Amoa-Bosompem
Boguslawa Luzak Michael Bette
Boris Chernyak Michael Bukrinsky
Boris Kantor Michael Chapman
Boris Yakobson Michael Eller
Bradley Groveman Michael Liebman
Bratko Filipic Michael Perch
Brenda S. Konigheim Michael Rahe
Brendan Bell Michael Roggendorf
Brian Crook Michael Schreiber
Brian Lee Michael Winkler
Brian Salmons Michaela Gack
Brigitta Marcella Laksono Michal A. Rahat
Brigitte Hantusch Michele Tonelli
Bruna Ramos Mick Mulders
Byung-Hoon Jeong Mihaela Hostiuc
Cameron Tebbi Mihaela Kavran
Carla Masala Mihaela Luca
Carla Miranda Mihnea Bostina
Carla Zannella Min Guo
Carlos Cerdán Santacruz Minetaro Arita
Carlos Sandoval-Jaime Minghang Wang
Carlos São-José Mingsong Kang
Carmen Jerry Minsook Hwang
Carmina Gallardo Frontaura Mirjana Jerkic
Carmine Izzo Miroslav Glasa
Carol Chitko-McKown Modra Murovska
Carolina Pacca Mohamad S. Hakim
Carolyn Teschke Mohamed Hassan
Catherine Alex Mohamed Mahdi
Catherine Brown Mohammad Sadraeian
Catherine Eichwald Mohammed Noushad
Catherine Loc-Carrillo Mohammed Rohaim
Cécile-Marie Aliouat-Denis Mohd Imran
Celia Fernandez-Ortega Mohd Zulkifli Salleh
Chandrabose Selvaraj Moises Leon Juarez
Changjun Huang Mona Sadat Larijani
Changming Bai Monika Olech
Charles Foster Monika Rinder
Charlotte Preston Morgan Brisse
Cheng Chi Mubarak S. Karsany
Cheng Guo Mudan Zhang
Cheng Huang Muhammad Iqhrammullah
Cheng Yan Muhammad N. Zahid
Chengwu Zou Muhammad Naveed Anwar
Chiara Agostinis Muhammad Nawaz
Chih-Ching Chung Münir Aktaş
Chitra Upadhyay Myriam Ermonval
Christian Barbato Nadia Storm
Christian Laboisse Nadine Krüger
Christina L. Gardner Najim Alshahrani
Christine Blattner Nasim Izadi
Christophe Guillon Natalia Cheshenko
Christophe Vanpouille Natalia Kovalskaya
Christopher Bellas Natalia Lomakina
Christopher Denes Natália Marques
Chukwunonso Onyilagha Natalia Mazur-Panasiuk
Chung-Hsin Wu Natalia Soriano-Sarabia
Chutchai Piewbang Naveen Kumar
Claire Muslin Nemat Sokhandan-Bashir
Claudia Wylezich Neven Papić
Clinton Jones Nicholas Bradshaw
Côme Thieulent Nicholas Eyre
Concetta Castilletti Nick Juleff
Congyue Peng Nicolas Ruggli
Conxita Mestres Nicole Vidal
Corrado Pelaia Nicolò Brandi
Craig Brunetti Nicolò Fabbri
Cristian Baicus Nidia Arechiga-Ceballos
Cristian-Mihail Niculae Nikolai Nikitin
Cristina Mambet Nikolaos Giormezis
Crystall Swarbrick Nikolaos V. Sipsas
Dan Heller Nina Tikunova
Dana Sabir Nina Wolfrum
Daniel Cisterna Nirajkumar Makadiya
Daniel Gonzalez-Dunia Nityanand Jain
Daniel Pérez-Núñez Nobuhiru Suzuki
Daniel Potaczek Noelia Nuñez-Ortiz
Daniel Salamango Norbert J. Roberts Jr.
Daniel Scott Noula Shembade
Daniela Elena Serban Noura Dosoky
Daniele Focosi Noureddine Issaoui
Danijela Černe Nourolah Soltani
Danijela Miljanovic Nuno Taveira
Danillo Lucas Alves Esposito Nuria Torner
Danuta Januszkiewicz-Lewandowska Olga Ivanova
Dapeng Wang Olga Krestinina
Daria Danilenko Olga Matveeva
David Baum Oliver Planz
David Burke Oliver Van Oekelen
David Davido Olivier Escaffre
David Martin Ombretta Turriziani
David Ornelles Omid Rezahosseini
David Scheim Osama Atallah
David Scott McVey Osman Aktaş
Dawei Zhou Otávio Augusto Chaves
De Gaulle I. Chigbu Otávio Espíndola
Debashis Dutta Owais Khan
Deemah Dabbagh Pakieli H. Kaufusi
Demetrios Arvanitis Pamuk Bilsel
Denise Hemmings Panagiotis Katsoulos
Dennis Bideshi Panagiotis Tassis
Der-Shan Sun Paola Dall’Ara
Désirée Caselli Paola Sinibaldi
Dewald Schoeman Paolo Monini
Diane Addie Paolo Pozzi
Dianjun Cao Parikshit Bagchi
Dilber Ipek Kurtboke Partha Chandra
Dimitri Kakabadse Partha Ray
Dimitrios Skliros Pasquale Marrazzo
Dimitris Tsakogiannis Pasquale Saldarelli
Dinesh Devadoss Patrick Gérardin
Dinesh Gawande Patrizia Danesi
Djamal Brahim Belhaouari Paul Azzinaro
Dmitry Kireev Paul Hyman
Dmitry S. Karpov Paul Kupke
Dmytro Chumachenko Paul Rösch
Domenico Galante Paula Rozo-Lopez
Domenico Marson Paulo Zaini
Dominic Paquin Proulx Pavel Alexyuk
Dominik Radzki Pavel Nazarov
Donald E. Spratt Pavel Solopov
Donald M. Coen Pavle Banovic
Dongbo Jiang Paweł Bęczkowski
Dong-Yan Jin Paweł Wańkowicz
Douwe Sinderen Pawel Zmora
Dulani Meedeniya Pedro Ramos-González
Duomeng Yang Pedro Serra
Edgar Simulundu Peli Foka
Edmund Kozieł Pengfei Ding
Eduardo Gomez-Casado Pero Lučin
Eduardo Gutiérrez-Abejón Perumal Renukadevi
Efstathios S. Giotis Peter Evseev
Eileen Roulis Peter Gaskill
Elcio Leal Peter Nagy
Elena Criscuolo Petr Zeman
Elena Frolova Philip Serwer
Elena Ryabchikova Phillip Tai
Eleonora Cimini Phuong Thi Hoang
Elisa Cairrao Pietro Hiram Guzzi
Elizaveta Starodubova Piyush Baindara
Elliott Chiu Pradeep Uchil
Elrashdy Redwan Pragya Yadav
Elsa Damonte Prashant Sharma
Elton Vasconcelos Qiang Liu
Elvan Üstün Qibin Geng
Elvina Viennet Qin Xiang Ng
Elzbieta Kierzek Rafael Rivera-Bustamante
Emad Beshir Ata Rafaela Fernandes
Emily Edwards Rafaella Ioshino
Emma Mohr Raffaele Serra
Emmanouil Magiorkinis Raghunadharao Digumarti
Emmanuelle Muller Rahima Benhabbour
Engy Elekhnawy Rajiv Pathak
Enrique Domínguez-Álvarez Ramanjaneyulu Rayala
Erez Bar-Haim Ramin Raul Ossami Saidy
Eric Huet Randal N. Johnston
Eric Lau Raphaël Duval
Eric Romanowski Raphael Tze Chuen Lee
Eric S. Pringle Rashad El-Hind
Eric Schott Raul Machado
Erich Mackow Ravendra Chauhan
Ernesto Quesada Ravinder Kumar
Esperanza Gomez-Lucia Rebecca Creamer
Esteban Finol Rebecca DuBois
Estela Paz-Artal Rebecca Rose
Eugene Ryabov Rebecca Sumner
Eui Tae Kim Regragui Taki
Eunsil Park Reiner Ulrich
Éva Áy Reka Varnai
Eva Varallyay Renata Oliveira
Evandro Watanabe Rendi Jiang
Evangelia Antoniou René Huber
Evgenii Rubalskii Renu Khasa
Evgeny Ermakov Reza Khayat
Ewa Tomaszewska Rhitajit Sarkar 
Ewoud B. Compeer Ricardo Lucena
Ezequiel Fuentes-Pananá Ricardo Parreira
Fabian Giolitti Riccardo Moretti
Fábio Abade Dos Santos Riccardo Nevola
Fabio Fiorino Richard Williams
Fabio Possebon Rik De Swart
Fabio Romerio Rita Ribeiro
Fabrício S. Campos Ritthideach Yorsaeng
Fabrizio Angius Rob Hoeben
Faez Amokrane Nait Mohamed Robert Flisiak
Fanfan Zhang  Robert Nastasa
Fangfang Sun Robert Yung Liang Wang
Fangfeng Yuan Roberta Antonia Diotti
Fareeha Saadi Roberta Battistini
Fátima Amaro Roberto De Masi
Fatma Eldemery Rodrigo Rodrigues
Fayna Diaz-San Segundo Roger Grand
Federica Fogacci Roland Marquet
Federico Armando Roland Zell
Federico Marchesi Rollie Clem
Felicia Grasso Ronan Murphy
Fernando Ferreira Ronghong Hua
Filipe Abreu Ronit Sarid
Filomena Fonseca Rosa Suades
Filomena Napolitano Rosamaria Pennisi
Flor Helene Pujol Roseli Nomura
Florence Abravanel Rosilainy Fernandes
Florence Fouque Ross Larue
Florence Larrous Rossella Cacciola
Florence Nicot Rozeta Sokou
Florencia Cancela Ruben Cloete
Floris Breman Rudian Zhang
Francesco Maria Fusco Rudolf Valenta
Francesco Messina Ruining Wang
Francesco Mira Ruisong Yu
Francesco Sessa Rupy Matharu
Francisco Guillen-Grima Ryan Troyer
Francisco José Nunes Antunes Ryo Okada
Francisco Reynaldi Saeid Ghavami
Franco Mutinelli Saito Akatsuki
Franz-Georg Hanisch Sakshi Arora
Fusheng Si Salim Manoharadas
Gábor Kökény Samar Tharwat
Gábor Nagy Samer Al Ghour
Gabriela Condezo Samir Casseb
Gabriela Goujgoulova Samrat Kumar Dey
Gabriela Mellado-Sanchez Samrita Dogra
Gabriela Popa Samuel Campos
Gabriela Toomer Sanchita Das
Gaetan Ligat Sandip Chavan
Gang Ye Sandra Adams
Gautier Moroy Sandra Högler
Geoffrey Holm Sandrama Nadan
Georges Herbein Santa Rasa-Dzelzkaleja
Georgios Pappas Santiago Garcia-Vallve
Gergana Zahmanova Santiago Mirazo
Gerhard Steger Santosh Dhakal
German Botto Nuñez Santosh George
German Gornalusse Sara Louise Cosby
Gert Venter Sara Morón-López
Gervais Habarugira Sara Querido
Ghassan Ghssein Sarah Jackson
Gianluca Spiteri Sarah Kempster
Gianpiero Zamperin Satoru Watanabe
Gilbert Holyoak Saumya Anang
Gilbert Nchongboh Chofong Sayanta Bera
Gill Diamond Sayed Abdelwahab
Giorgio Gallinella Sayed Sartaj Sohrab
Giorgio Mangino Schuyler Van Engelenburg
Giovanni Battista Gaeta Sebastiano Cicco
Giulia Tarquini Sek-Man Wong
Giuseppe Bruno Semer Maksoud
Giuseppe Di Martino Sergei Chirkov
Gloria Ramirez-Nieto Sergei Nikolaevich Shchelkunov
Gonzalo Izaguirre Sergei Raev
Gordana Wozniak Knopp Sergey Iordanskiy
Graham Belsham Sergey Kapranov
Graham Burgess Sergey Morozov
Grazia Pavia Sergey Sedykh
Greg Brennan Sergey Tkachev
Grissell Tirado Seri Jeong
Grzegorz Grześk Shabana Bibi
Grzegorz Jakubiak Shagufta Perveen
Guanghui Wu Shalini Dogra
Guanglin Zhang Shangrong Fan
Guido Vanham Shaoquan Zheng
Gulce Sari Sharat Chandra
Gun Temeeyasen Sharon Andreason
Gustavo Caetano-Anollés Sheng Qin
Gustavo Silva Shengqun Deng
Guy Lemay Shengren Sun
Gwladys Gernoux Shengxi Chen
Hafez M. Hafez Shiba Dandpat
Hagen Frickmann Shifali Shishodia
Haidi Ramadan Shih-Chieh Shao
Haiyan Yang Shivalee Duduskar
Halilibrahim Ciftci Shu Yuan
Han Siong Toh Shuchen Feng
Hana Dobrovolny Shukho Kim
Hang Su Shuntai Zhou
Hanns Moshammer Shuya Yang
Hans-Gerhard Burgert Silvia Faccini
Hansjörg Lehnherr Silvia González
Hao Wang Simone König
Haolong Dong Singh Avishek
Hardik Dineshbhai Desai Slavica Kvolik
Harriet C. Groom Sohrab Ahmadivand
Haruka Abe Sonia Lozano Sepulveda
Hassanein Abozeid Sonia Moretti
Hayley Yaglom Sonsoles Salto-Alejandre
Hazem Elkady Sotirios N. Kiokias
He Sun Sowmyalakshmi Subramanian
He Zhang Sreekumar Othumpangat
Heba Zaghloul Srinivasa Reddy Bonam
Hector Rangel Srinivasan Palani
Hedvig Bölcskei Stefan Oliver
Heinzpeter Schwermer Stefan Vilcek
Hélène Sanfaçon Stefania Lauzi
Heliana Dundarova Stefano Pascarella
Helle Bielefeldt-Ohmann Stefano Rusconi
Hengchang Chen Stephan Pleschka
Henry Sutanto Stephen A. Rice
Herbert Treutlein Stephen Morris
Hidekazu Hiroaki Steven Baker
Hideo Wada Steven Van Borm
Hideto Fukushi Steven Zink
Hi-Eun Jung Stuart Dowall
Hiroaki Okamoto Subbiah Thamotharan
Hiroyasu Sakai Subha Das
Hisayoshi Kawahara Suchitra Mohanty
Ho-Jong Ju Sudhir Morla
Hon S. Ip Suman Alishetty
Hongbo Zhou Suman Lata Wattal
Hongzhuan Wu Suresh Varsani
Hua Wang Sutonuka Bhar
Hua-Ji Qiu Sveinung Sorbye
Hugo Ramírez Álvarez Sylvain De Breyne
Hye Kwon Kim Tae-Jin Choi
Hye Ryoung Kim Tahir Farooq
Hye-Ra Lee Takahiro Kawagishi
Hyun Jin Kwun Takahiro Sanada
Hyun-Ouk Kim Takashi Onodera
Hyun-Woo Park Takashi Yoshiyama
Ian Barr Takayuki Nitta
Ibrahim Sayed Takeshi Kawaguchi
Ida Steinberger-Levy Takuya Tada
Igor Andrade Santos Tal Noy Porat
Igor Babkin Talia Swartz
Igor Jurak Talita Resende
Igor Maksimov Tamás Letoha
Igor Oscorbin Tanel Punga
Ikbal Agah Ince Tanushree Dangi
Ilya M. Terenin Tao Wang
Ilze Strumfa Tao Zhu
Imaan Benmerzouga Tara M. Strutt
Iman Tavassoly Taro Urase
Ines Aguinaga-Ontoso Tatiana Komarova
Inês Bártolo Tatjana Vilibic-Cavlek
Ingo Drexler Tatsunori Nakano
Ingrid Friesema Tatsuo Kanda
Inna Solyanikova Tatsuya Yamazaki
Ioannis G. Kyriakoulis Tatyana Ilyicheva
Ioannis Giantsis Tea Glonti
Irena Ilic Teddy Lazebnik
Irena Tabain Terence Scott
Irene Görzer Terenzio Cosio
Irene Ramos Teruhime Ootoguro
Irene Righetto Tetsuro Ikegami
Irina Isakova-Sivak Thiago Murari
Irina Kiseleva Thomas Dandekar
Isabel Muñoz-Barroso Tianjie Pu
Italo Tempera Tim Mahony
Itzel López-Rosas Tim Sit
Ivan Gladwyn-Ng Tiziana Bachetti
Ivan Sabol Todd Smith
Ivana Lazarevic Tom Gallagher
Ivanildo Sousa Tomasz Krzysztof Oszako
Ivo Sirakov Tomozumi Imamichi
Iwao Kukimoto Tong Wang
J. Stephen Lodmell Tongjun Guo
Jacques Robert Toru Takimoto
Jacques Scheres Trevor Williams
Jaggi Ujjaldeep Triantafyllos Didangelos
Jaime Sancho Trudy G Morrison
James Chung-Wai Cheung Tsung-Chi Chen
James Gillespie Tuba Çiğdem Oğuzoğlu
James Harris Tudor Borza
James Van Etten Tudor Lucian Pop
Jana Sopkova De Oliveira Santos  Tutku Beduk
Janet Mans Tze-Kiong Er
Janet Nale Umberto Palatini
Janis Müller Umberto Rosani
Janja Trček Urmi Roy
Jaquelin Dudley Usama Abdelmohsen
Jarosław Walory Usama Ashraf
Jasminka Peršec Valerio Giaccone
Jay R. Radke Valerio Leoni
Jayeshbhai Chaudhari Vanessa Meier-Stephenson
Jean Bettoni Vangelis Daskalakis
Jean Daugrois Vanja Kaliterna
Jean Vanderpas Velmurugan Balaraman
Jean-Pierre Frossard Venkatesan Jayaprakash
Jean-Pierre Gagner Venkatraman Siddharthan
Jelena Prpić Verónica Truniger
Jennifer Corcoran Véronique Ziegler-Graff
Jennifer Moffat Vesna Milicevic
Jens Andre Hammerl Vicente Notario
Jeong Yoon Lee Vicente Pallás
Jeová Colares Victor M. Petrone-Garcia
Jerel A. Fields Vida Van Staden
Jeremy Camp Vikram Dalal
Jesse Arbuckle Vinay Shivanna
Jesse Deere Violetta Macioszek
Jessica Kevill Virginia Lotti
Jessy Vibin Virginie Doceul
Jesús Hernández Vishal Singh Negi
Jesús Zepeda-Cervantes Vishi Reddy
Ji Bao Vishma Pratap Sur
Jiafen Hu Vivaldo Gomes Da Costa
Jian Zhang Vivian De Oliveira
Jianchao Zhang Vivian O'Donnell
Jianing Chen Viviana Parreño
Jianjun Zhao Vladimir I. Timofeev
Jianpiao Cai Vladimir Savic
Jianzhu Liu Vladimir Yeremeev
Jiarong Jheng Volker Schmidt
Jiazhang Wei Volodymyr Oberemok
Jienyu Ding Vrinda Gote
Jieshi Yu Vyacheslav Yurchenko
Jiexiong Xie Waldemar Wagner
Jillian Myers Wanbiao Ma
Jimmy T. Efird Wei Ye
Jin Il Kim Wei-Fan Hsu
Jinlong Han Weiheng Su
Jinming Han Wei-June Chen
Jinyan Zhang Weiren Luo
Jinyang Zhang Wen Deng
Jiwei Ding Wenchao Sun
Joan L. Kenney Wenjun Zhu
Joana Vitallé Wojciech Rozek
Joanna Maj-Paluch Wolfram Gerlich
Joanne Hiebert Won Kyong Cho
Joe Mymryk Xiangjie Sun
Joel Ellwanger Xiaochun Peng
John Sinclair Xiaodong Xu
Joice Ruggeri Xiaofan Li
Jonathan Griffiths Xiaoming Lyu
Jonathan LeCureux Xiaoying Yu
Jonathan Rayner Xin Li
Joon Kee Lee Xinhong Chen
Jorge Padrão Xinran Liu
Jorlan Fernandes Xizhou Zhu
José A. Carrión Xudong Fan
Jose A. Garrote Xuefei Tan
José Affranchino Xuehong Wu
José Cuevas Xulin Chen
José Leopoldo Aguilar-Faisal Y. B. Basavaraj
Jose Ramos-Vivas Yahya Al Naggar
Josep Quer Yahya Gaafar
Joseph Westrich Yanal Murad
Josko Markic Yanan Liu
Joydip Sengupta Yihong Xiao
Jozef Bujarski Yinzhong Shen
Jozsef Dudas Yiwen Zhao
Juan Bárcena Yolande Thérèse Rose Proroga
Juan Degiuseppe Yong Gao Peng
Juan E. Ludert Yong Shao
Juan Fidel Osuna-Ramos Yong Teng
Juan Hernandez-Garcia Yongduo Sun
Juanita Van Heerden Yonggang Pei
Juhee Ahn Yoshiaki Yura
Julia Davydova Yousong Peng
Julian Freen-van Heeren Yu-Chung Chang
Julián Ruiz-Sáenz Yuefan Song
Julián Solís García del Pozo Yung-Cheng Lin
Julie Fox Yusra Habib Khan
Julio Plaza Díaz Yusuke Matsumoto
Jumari Snyman Yutaka Tagaya
Jun Arii Zbigniew Heleniak
Jun Chen Zhanying Hu
Jun Luo Zhaoxi Sun
Junfa Yuan Zhen Li
Junfeng Gao Zheng Chen
Jung-Eun Park Zhenlu Chong
Junichi Inaba Zhenyu Zhang
Junping Hong Zhijun Yu
Junqing Guo Zhonglei Wang
Juris Jansons Zifu He
Jutta Pikalo Zisis Kozlakidis
Kai Xu Zoltan Peterfi
Kai Zheng Zoltan Vajo
Kaichuang Shi Zoran Todorovic
Kaili Ma Zsolt Toth
Kai-Shu Ling Zulqurnain Khan

23 January 2024
Prof. Dr. Svetlana Y. Folimonova Appointed Associate Editor of Section “Viruses of Plants, Fungi and Protozoa” in Viruses


We are pleased to announce that Prof. Dr. Svetlana Y. Folimonova has been appointed Associate Editor of the Section “Viruses of Plants, Fungi and Protozoa” of Viruses (ISSN: 1999-4915).

Name: Prof. Dr. Svetlana Y. Folimonova
Homepage: https://plantpath.ifas.ufl.edu/people/faculty-pages/svetlana-folimonova/
Affiliation: Department of Plant Pathology, Plant Molecular and Cellular Biology Graduate Program, University of Florida, Gainesville, FL 32611, USA
Interests: RNA viruses; long noncoding RNAs; plant viruses; virus–host interactions; viral and bacterial diseases of citrus; citrus tristeza virus

Prof. Dr. Folimonova is a Professor at the University of Florida, USA. Her research program focuses on viral diseases of plants, in particular, diseases caused by the largest nonsegmented plant RNA virus, citrus tristeza virus. Prof. Dr. Folimonova’s primary research effort is concentrated on understanding the mechanisms of the infection process, host responses to viruses, improving methods of detection, and developing management strategies for viral diseases.

We are honored that we have the opportunity to introduce Prof. Dr. Svetlana Y. Folimonova to our editorial team, and we are confident that, with the guidance of our new Associate Editor, we will continue to improve the reputation and quality of Viruses.

For more information about the “Viruses of Plants, Fungi and Protozoa” Section, please visit the following link: https://www.mdpi.com/journal/viruses/sections/plant_viruses.

Viruses Editorial Office

Back to TopTop